Merck & Co Inc has announced plans to acquire privately-held Afferent Pharmaceuticals of San Mateo, California, US for up to $1.25 billion depending on the achievement of specific clinical and commercial milestones. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
